UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Sickle cell disease; a general overview

Netherlands journal of medicine, 2004-11, Vol.62 (10), p.364-374

2004

Link zum Volltext

Verfügbarkeit prüfen

Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis

Biochemical and biophysical research communications, 2009-12, Vol.390 (1), p.161-164

2009

Link zum Volltext

Verfügbarkeit prüfen

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease

Annals of hematology, 2005-05, Vol.84 (5), p.282-286

2005

Link zum Volltext

Verfügbarkeit prüfen

An unusual craving

Netherlands journal of medicine, 2015-02, Vol.73 (2), p.96

2015

Link zum Volltext

Verfügbarkeit prüfen

Protein C and S and inflammation in sickle cell disease

American journal of hematology, 2004-05, Vol.76 (1), p.26-32

2004

Link zum Volltext

Verfügbarkeit prüfen

Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype

Blood cells, molecules, & diseases, 2010-04, Vol.44 (4), p.229-232

2010

Link zum Volltext

Verfügbarkeit prüfen

Elevated IL-8 levels during sickle cell crisis

European journal of haematology, 1998-11, Vol.61 (5), p.302-305

1998

Link zum Volltext

Verfügbarkeit prüfen

Low adjusted‐dose acenocoumarol therapy in sickle cell disease: A pilot study

American journal of hematology, 2001-11, Vol.68 (3), p.179-183

2001

Link zum Volltext

Verfügbarkeit prüfen

Steady-state sVCAM-1 serum levels in adults with sickle cell disease

Annals of hematology, 2003-02, Vol.82 (2), p.109-113

2003

Link zum Volltext

Verfügbarkeit prüfen

No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension

Haematologica (Roma), 2008-05, Vol.93 (5), p.e42-e44

2008

Link zum Volltext

Verfügbarkeit prüfen

Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease

Annals of hematology, 2003-03, Vol.82 (3), p.171-174

2003

Link zum Volltext

Verfügbarkeit prüfen

Duffy Phenotype Does Not Influence the Clinical Severity of Sickle Cell Disease

Clinical immunology (Orlando, Fla.), 2000-09, Vol.96 (3), p.264-268

2000

Link zum Volltext

Verfügbarkeit prüfen

No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease

American journal of hematology, 2002-09, Vol.71 (1), p.53-55

2002

Link zum Volltext

Verfügbarkeit prüfen

Increased Serum Levels of Anti-Angiogenic Factors Soluble fms-Like Tyrosine Kinase and Soluble Endoglin in Sickle Cell Disease

Acta haematologica, 2008-01, Vol.120 (3), p.130-133

2008

Link zum Volltext

Verfügbarkeit prüfen

Elevated Circulating Stromal-Derived Factor-1 Levels in Sickle Cell Disease

Acta haematologica, 2009-01, Vol.122 (1), p.64-69

2009

Link zum Volltext

Verfügbarkeit prüfen

Folate status assessment and folic acid supplements in sickle cell disease

Journal of pediatric hematology/oncology, 2001-11, Vol.23 (8), p.548-548

2001

Link zum Volltext

Verfügbarkeit prüfen

Plasma homocysteine levels in sickle cell disease and the need for folate supplementation

Journal of pediatric hematology/oncology, 2000-03, Vol.22 (2), p.184-185

2000

Link zum Volltext

Verfügbarkeit prüfen

Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice

Haematologica (Roma), 2008-05, Vol.93 (5), p.757-760

2008

Link zum Volltext

Verfügbarkeit prüfen

Sickle cell patients are characterized by a reduced glycocalyx volume

Haematologica (Roma), 2008-02, Vol.93 (2), p.307-308

2008

Link zum Volltext

Verfügbarkeit prüfen

Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients

American journal of hematology, 1998-11, Vol.59 (3), p.192-198

1998

Link zum Volltext

Verfügbarkeit prüfen

New concepts in assessing sickle cell disease severity

American journal of hematology, 1998-05, Vol.58 (1), p.61-66

1998

Link zum Volltext

Verfügbarkeit prüfen

An unusual craving

The Netherlands journal of medicine, 2015, Vol.73 (2), p.96-96

2015

Link zum Volltext

Verfügbarkeit prüfen

An analytical view of the BJH publication of ‘a clinician's view of voxelotor’

British journal of haematology, 2023-03, Vol.200 (6), p.e56-e57

2023

Link zum Volltext

Verfügbarkeit prüfen

An urgent call to raise the bar in oncology

British journal of cancer, 2021-11, Vol.125 (11), p.1477-1485

2021

Link zum Volltext

Verfügbarkeit prüfen

Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management

American journal of hematology, 2011-06, Vol.86 (6), p.484-489

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(55)
Berichte
(1)

Sprache

Englisch
(56)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(47)
Science & Technology
(47)
Humans
(43)
Hematology
(36)
Adult
(31)
Female
(28)
Male
(27)
Anemia, Sickle Cell - Blood
(26)
Middle Aged
(24)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Sickle Cell Disease
(21)
Hematologic And Hematopoietic Diseases
(20)
Anemias. Hemoglobinopathies
(19)
Diseases Of Red Blood Cells
(19)
Anemia, Sickle Cell - Complications
(15)
Young Adult
(10)
Adolescent
(8)
Anemia, Sickle Cell - Physiopathology
(8)
Vascular Cell Adhesion Molecule-1 - Blood
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sickle cell disease; a general overview

Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease

An unusual craving

Protein C and S and inflammation in sickle cell disease

Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype

Elevated IL-8 levels during sickle cell crisis

Low adjusted‐dose acenocoumarol therapy in sickle cell disease: A pilot study

Steady-state sVCAM-1 serum levels in adults with sickle cell disease

No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension

Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease

Duffy Phenotype Does Not Influence the Clinical Severity of Sickle Cell Disease

No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease

Increased Serum Levels of Anti-Angiogenic Factors Soluble fms-Like Tyrosine Kinase and Soluble Endoglin in Sickle Cell Disease

Elevated Circulating Stromal-Derived Factor-1 Levels in Sickle Cell Disease

Folate status assessment and folic acid supplements in sickle cell disease

Plasma homocysteine levels in sickle cell disease and the need for folate supplementation

Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice

Sickle cell patients are characterized by a reduced glycocalyx volume

Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients

New concepts in assessing sickle cell disease severity

An unusual craving

An analytical view of the BJH publication of ‘a clinician's view of voxelotor’

An urgent call to raise the bar in oncology

Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management

Suchergebnisse filtern